IDEOM REVIEWED
PUBLICATIONS SINCE 2013


1. Gottlieb AB1, Armstrong AW. Psoriasis outcome measures: a report from the GRAPPA 2012 annual meeting. August 2013: J Rheumatol. 2013 Aug;40(8):1428-33. doi: 10.3899/jrheum.130456.


2. Gottlieb AB1, Armstrong AW1, Christensen R1, Garg A1, Duffin KC1, Boehncke WH1, Merola JF1, Gladman DD1, Mease PJ1, Swerlick RA1, Rosen CF1, Abernethy A1. The International Dermatology Outcome Measures initiative as applied to psoriatic disease outcomes: a report from the GRAPPA 2013 meetingJune 2014: J Rheumatol: 41(6):1227-9. doi: 10.3899/jrheum.140176


3. Patients become full partners in inflammatory arthritis and psoriasis research July 15, 2014: Dermatology News: By: Ted Bosworth, Dermatology News Digital Network.


4. International group seeks to close gaps in psoriasis research April 2, 2014: From AAD Summer Academy Meeting News


5. Varada, Sowmya & Kim, Noori & Abernethy, April & Armstrong, April & Callis-Duffin, Kristina & Garg, Amit & Gottlieb, Alice. (2014). IDEOM: International Dermatology Outcome Measures - Proceedings from the First Meeting. Psoriasis Forum. 20a. 66-72. 10.1177/247553031420a00207.


6. B Gottlieb, Alice & A Levin, Adriane & Armstrong, April & Abernethy, April & Duffin, Kristina & Bhushan, Reva & Garg, Amit & Merola, Joseph & Maccarone, Mara & Christensen, Robin. (2014). The International Dermatology Outcome Measures Group: Formation of patient-centered outcome measures in dermatology. Journal of the American Academy of Dermatology. 72. 10.1016/j.jaad.2014.11.002.


7. James A. Solomon, M.D., Ph.D., Ryan Schuering, B.S. An Update on The IDEOM (International Dermatology Outcome Measures) Initiative to Restructure Current Psoriasis Outcome Assessment Measures to a Globally Uniform Set of Patient-Centric Outcome Measures for Use in Clinical Trials and Clinical Practice.Spring 2015: Psoriasis Forum, Vol. 21, No. 1.


8. Greb JE, Merola J, Garg A, Latella J, Howard L, Acharya N, Gottlieb AB, Perez-Chada LM, Singh S, Callis-Duffin K, Garg A, Gottlieb AB, Latella J, Armstrong, AW, Merola JF. The Psoriatic Disease Payer Advisory Panel. J. Drugs in Dermatol. 15: 641-644, 2016.


9. Greb JE, Merola J, Garg A, Latella J, Howard L, Acharya N, Gottlieb AB Elman SA, Merola JF, Armstrong AW, Callis Duffin K, Latealla J, Garg A, Gottlieb AB: The International Dermatology Outcome Measures (IDEOM) Initiative: A Review and Update. The Psoriatic Disease Payer Advisory Panel. J. Drugs in Dermatol. 15: 641-644, 2016. J.Drugs Dermatol. 16:119-124, 2017.


10. Thorlacius L, Ingram JR, Garg A, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, Merola JF, Dellavalle R, Christensen R, Jemec GBE. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes. BMJ Open 2017;7(2):e014733.


11. Callis Duffin K, Merola JF, Christensen R, Latella J, Garg A, Gottlieb AB, Armstrong AW. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials:A Combined Delphi Consensus Survey from the International Dermatology Outcome Measures Initiative, JAMA Dermatology, Published online June 6, 2018. doi:10.1001/jamadermatol.2018.1165


12. Gottlieb AB, Merola JF, Chen r, Levi E, Callis Duffin K: Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA x BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data. JAAD 77: 1178-1180, 2017.


13. Gottlieb AB, Kirby B, Ryan C,Naegeli AN, Burge R, Bleakman AP, Anatchkova MD, Yosipovitch G. The development of a patient-reported measure for assessment of genital psoriasis symptoms: The genital psoriasis symptoms scales (GPSS). Dermatology and Therapy published online. https://doi.org/10.1007/s135555-017-0213-2, 2017


14. Gottlieb AB, Kirby B, Ryan C, Naegeli AN, Burge R, Bleakman AP, Anatchkova MD, Cather J: The development of the genital psoriasis sexual frequency questionnaire (GenPs-SFQ) to assess the impact of genital psoriasis on sexual health. Dermatology and Therapy, published online. https://doi.org/10.1007/s13555-017-0212-3, 2017


15. Thorlacius L, Ingram JR, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, Merola JF, Dellavalle R, Nielsen SM, Christensen R, Garg A and Jemec GBE, on behalf of the HIdradenitis SuppuraTiva cORe outcomes set International Collaboration (HISTORIC). A Core Domain Set For Hidradenitis Suppurativa Trial Outcomes: An International Delphi Process. Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16672


16. Thorlacius L, Garg A, Ingram JR, Villumsen B, Theut Riis P, Gottlieb AB, Merola JF, Dellavalle R, Ardon C, Baba R, Bechara FG, Cohen AD, Daham N, Davis M, Emtestam L, Fernandez-Penas P, Filippelli M, Gibbons A, Grant T, Guilbault S, Gulliver S, Harris C, Harvent C, Houston K, Kirby JS, Matusiak L, Mehdizadeh A, Mojica T, Okun M, Orgill D, Pallack L, Parks-Miller A, Prens E, Randel S, Rogers C, Rosen CF, Choon SE, van der Zee HH, Christensen R, Jemec GBE. Towards global consensus on core outcomes for Hidradenitis Suppurativa research: An update from the HISTORIC consensus meetings I and II. Br J Dermatol. 2018;178(3):715-721.


17. Joseph F. Merola, David A. Amato, Kyoungah See, Russel Burge, Craig Mallinckrodt, Clement K Ojeh, Alice Gottlieb. Evaluation of sPGAxBSA as an outcome measure and treatment target for clinical practice. J. Invest. Dermatol. J Invest Dermatol. 2018 Mar 22. pii: S0022-202X(18)31741-X. doi: 10.1016/j.jid.2018.01.041. [Epub ahead of print]


18. Salame N, Perez-Chada LM, Singh S, Callis Duffin K, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong AW. Are Your Patients Satisfied? A Systematic Review of Treatment Satisfaction in Psoriasis. Dermatology, in press.


19. Salame N, Torres J, Sandhu J, Callis Duffin K, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong AW. Patient-Reported Outcome Measures for Pediatric Psoriasis: A Systematic Review and Critical Appraisal from International Dermatology Outcome Measures (IDEOM). Dermatology, in press


20. Joseph F. Merola, David A. Amato, Kyoungah See, Russel Burge, Craig Mallinckrodt, Clement K Ojeh, Alice Gottlieb: Evaluation of sPGAxBSA as an outcome measure and treatment target for clinical practice. J. Invest. Dermatol. J Invest Dermatol. 2018 Mar 22. pii: S0022-202X(18)31741-X. doi: 10.1016/j.jid.2018.01.041. [Epub ahead of print]; 138:1955-1961. 2018.


21. Perez-Chada LM, Cohen JM, Gottlieb AB, Duffin KC, Garg A, Latella J, Armstrong AW, Ogdie A, Merola JF. Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative. Archives of dermatological research. 2018 Aug 25:1-0. more...

22. MD, PhD Alice Gottlieb, Nicole Salame, BA, April W. Armstrong, MD, MPH, Joseph F. Merola, MD, MMSc, Sylvia Parra, MD, Junko Takeshita, MD, PhD, MSCE, Suephy C. Chen, MD, MS, John Latella, BS, MS, Marta Van Beek, MD, MPH; Journal of the American Academy of Dermatology: "A Provider Global Assessment Quality Measure for Clinical Practice for Inflammatory Skin Disorders" read more...